Freedom2 Public Relations

Freedom2 Inc. (Freedom2) is a US-based skin therapy company researching and developing products and applications based on the company's patented and patent-pending Particle Encapsulation and Enhancement (P2E) Platform. Conceived in 1999, by scientists at Massachusetts General Hospital, Duke University and Brown University in collaboration with some of the nation's leading physicians, chemists, tattoo artists and aesthecians, the P2E platform allows for a safer application of pigments, dyes and active pharmaceuticals to, through and/or under the skin by encapsulating them in (bio-degradable and non-biodegradeable) polymer-based particles.

Today Freedom2 markets body art, aesthetic, cosmetic and therapeutic products based on the P2E platform. From Infinitink, the first tattoo ink designed to be permanent and removable to NBlock, a new sunblock technology featuring the best ingredient for blocking UVA and UVB, Freedom2's mission is to provide products and applications that improve the health, look and vitality of peoples' largest organ—the skin.